- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Concord Biotech's Board approved FY26 consolidated financial results, posting a profit of ₹259.23 Cr. They proposed a ₹7.55/share dividend and appointed Mrs. Ekta Gupta as an Independent Director. Celliimune Biotech was also acquired. #CONCORDBIO